Listening to the community's needs, the Sickle Cell Consortium also created the Caregiver Summit, offering a vital space for ...

Thirty-five states have agreed to participate in a federal pilot program aimed at helping Medicaid patients access costly ...

Sickle cell has been overlooked for far too long. Fortunately, there are new breakthroughs in sickle cell treatment that you ...

Hydroxyurea remains effective long-term in reducing emergency department visits and hospital days for children living with sickle cell disease (SCD), according to new research published in Blood ...

Anesthesia Center for Critical Care Research, Department of Anesthesia, Critical Care, and Pain Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, United ...

Period-driven inflammation could influence the risk of pain events among women with sickle cell disease Levels of C-reactive protein increase among women with sickle cell disease during the first ...

Work likely to be halted by the cuts includes the collection of data for studying Americans with sickle cell, a painful blood disorder that predominantly affects Black families, as well as ...

The CDC’s Division of Blood Disorders ran the Sickle Cell Data Collection program, which assessed the long-term trends of treatment and access to health care for people living with sickle cell ...

NHS patients with sickle cell disease can now benefit from a groundbreaking gene-editing treatment that holds the potential to cure the condition. The one-off gene therapy, exagamglogene autotemcel ...

Bluebird Bio and Xcellbio have entered into an agreement to support the commercialization of Lyfgenia (lovotibeglogene autotemcel), Bluebird’s gene therapy for sickle cell disease, incorporating ...

The CSIR-Sickle Cell Anaemia Mission has so far screened close to 28 lakh persons across several States and found the prevalence of carriers and patients of Sickle Cell Anaemia (SCA) to be 8-10% ...

Centre for Cellular and Molecular Biology has announced the extension of its novel molecular test based screening for Sickle Cell Anaemia (SCA) to Jharkhand in association with Tata Steel ...